Overview

Overview

Leading the way toward the future of the diagnosis and treatment of cardiovascular disease, Boston Scientific is committed to providing less-invasive and more cost-effective treatment options. These options include the use coronary stent systems -- drug-eluting and bare metal stents -- and adjunctive devices for optimizing the procedure (PCI optimization). These devices include balloon angioplasty catheters, embolic protection devices, atherectomy devices, atheretomy devices, and ultrasound imaging systems.

Boston Scientific is conducting the industry’s most comprehensive program of clinical trials investigating the use of drug-eluting stents.